Summary
The Mycobacterium tuberculosis protein Rv2377c (71 residues, MW = 8.4 kDa) has been characterized using nuclear magnetic resonance (NMR) and circular dichroism (CD) spectroscopy. Rv2377c was the first identified member of the MbtH-like family of proteins. MbtH-like proteins have been implicated in siderophore biosynthesis, however, their precise biochemical function remain unknown. Size exclusion chromatography and NMR spectroscopy show that Rv2377c is a monomer in solution. Circular dichroism spectroscopy indicates that Rv2377c unfolds upon heating and will reversibly fold into its native conformation upon cooling. Using NMR-based methods the solution structure of Rv2377c was determined and some of the dynamic properties of the protein studied. The protein contains a three-strand, anti-parallel β-sheet (β3:β1:β2) nestled against one C-terminal α-helix (S44-N55). Weak or absent amide cross peaks in the 1H-15N HSQC spectrum for many of the β1 and β2 residues suggest intermediate motion on the ms to μs timescale at the β1:β2 interface. Amide cross peaks in the 1H-15N HSQC spectrum are absent for all but one residue at the C-terminus (W56 - D71), a region that includes a highly conserved sequence WXDXR, suggesting this region is intrinsically disordered. The latter observation differs with the crystal structure of another MbtH-like protein, PA2412 from Pseudomonas aeruginosa, where a second ordered α-helix was observed at the extreme C-terminus.
Keywords: tuberculosis, siderophore assembly, mycobactin, circular dichroism, structural genomics, protein dynamics
1. Introduction
Mycobacterium tuberculosis, the aetiological agent responsible for the chronic infectious disease tuberculosis (TB), annually kills 1.6 million people and newly infects another 8-9 million.1,2 These levels of TB infection show no signs of decreasing in the near future due to the emergence of multi-drug and extremely drug-resistant M. tuberculosis strains along with the prevalence of high human immunodeficiency virus infections.3-5 Conventional treatment of TB is a short course of multiple drugs over a long period of time, typically isoniazid, rifampin, pyrazinamide, and ethambutol for two months followed by isoniazid and rifampin for four months.6 While such a therapy is often successful, incomplete implementation contributes to the increasing levels of multi-drug (to at least isoniazid and rifampin) and extreme-drug (to isoniazid and rifampin plus three or more second-line agents) resistant M. tuberculosis strains.7 Consequently, it is of fundamental importance to develop a new generation of anti-TB agents.
One target of novel anti-TB drugs focuses on the disruption of the biochemical pathways responsible for the sequestration of iron by M. tuberculosis.8,9 Iron is an essential catalytic and structural component of many proteins10 and one of the defense mechanisms of infected eukaryotic hosts is to dramatically restrict its availability to the bacteria.11 To overcome iron deficiencies in the host, M. tuberculosis and other bacteria have evolved sophisticated iron-acquisition systems that make use of small molecules, called siderophores, that are excreted into extracellular space, bind available iron, and then reinternalized with the iron into the bacteria via specific cell surface receptors.12,13 M. tuberculosis produces two types of siderophores, called mycobactins, that are based on a 2-hydroxyphenyloxazoline-ring system and differ by the nature of a single fatty acyl side chain linked to the ε-amino group of N-hydroxy lysine.14-16 These two siderophores are biosynthesized through the action of a number of proteins located in a cluster of genes involved in nonribosomal peptide and polyketide synthesis.17 One of these genes encodes a small, 71-residue protein, MbtH,18 that is the founding member of the MbtH-like (Mycobacterium tuberculosis) family of proteins present in numerous non-ribosomal protein synthetase clusters responsible for siderophore and antibiotic peptide synthesis. The function of the MbtH-like proteins remain unknown with only one structure, PA2412 from Pseudomonas aeruginos,19 determined for the 150-plus members of this family. To obtain further insights into the biological function of the MbtH-like family of proteins that may enable the conception and development of new therapies and strategies to treat and control TB, the solution structure for the first member of the MbtH-like protein family, Rv2377c, has been determined by NMR-based methods. The dynamics of Rv2377c is explored, the solution structure compared to the crystal and solution structures of PA2412, and the thermostablity of Rv2377c assayed using circular dichroism spectroscopy.
2. Materials and Methods
2.1 Cloning, expression, and purification
The DNA coding sequence for the Rv2377c gene was cloned into a modified pET28b vector (Novagen, Madison, WI) that provided an N-terminal 6-histidine tag (MGSSHHHHHHSSGLVPRGSH-) upstream of the NdeI site. This recombinant vector was then transfected into the host Escherichia coli bacterial strain BL21PRO (Clontech, Palo Alto, CA). Uniformly 15N- and 15N-, 13C-labeled Rv2377c was obtained following established protocols that have been previously described in detail20 using the antibiotics kanamycin and spectinomycin during cell growth in minimal medium, isopropyl β-D-1-thiogalactopyranoside induction at 298 K, initial purification of the French pressed cell lysate on a Ni-NTA affinity column (Qiagen, Valencia, CA), thrombin cleavage of the N-terminal polyhistidine tag, and final purification on a Superdex75 HiLoad 10/30 column (GE Healthcare, Piscataway, NJ) that simultaneously exchanged Rv2377c into NMR buffer (300 mM NaCl, 20 mM TrisHCl, 1.0 mM dithiothreitol, pH 7.1). The final concentrations of the NMR samples were between 1 and 2 mM.
2.2 Optical spectroscopy
Circular dichroism data were collected on a Aviv Model 410 spectropolarimeter (Lakewood, NJ) calibrated with an aqueous solution of ammonium d-(+)camphorsulfonate. Measurements were obtained on a Rv2377c sample (0.06 mM) in NMR buffer and in a quartz cell of 0.1 cm path length. A thermal denaturation curve for Rv2377c was obtained by recording and plotting the ellipticity at 210 nm in 2.0°C intervals from 10 to 80°C. Wavelength scans for Rv2377c were recorded between 200 and 260 nm at 25°C, 80°C, and 25°C (post-heating) in 0.5 nm increments. Each wavelength spectrum was the result of averaging two consecutive scans with a bandwidth of 1.0 nm and a time constant of 1.0 s. The wavelength spectra were processed by subtracting a blank spectrum from the protein spectrum and then automatically line smoothing the data using Aviv software. A rough estimation of the elements of secondary structure in the protein at 25°C, presented in Table 2, was obtained by deconvoluting the spectrum using Aviv software.
Table 2. Elements of secondary structure in Rv2377c as determined from the NMR structure and estimated from the deconvolution of the CD spectrum.
Method | α-helix | β-strand | turn | random coil |
---|---|---|---|---|
NMR | 16% | 20% | 22% | 42% |
CD | 29% | 20% | 18% | 33% |
2.3 NMR spectroscopy and resonance assignments
All NMR experiments were collected on 1 - 2 mM samples at 25°C using Varian 900-, 750-, 600- and 500-Inova spectrometers equipped with triple resonance probes and pulse field gradients. The data were processed with Felix2007 (Felix NMR, Inc., San Diego, CA) and analyzed with Sparky (v3.115). All chemical shifts were referenced to DSS (DSS = 0 ppm) using indirect methods.21
The 1H, 13C, and 15N chemical shifts of the backbone and side chain resonances were obtained from standard two-dimensional 1H-15N and 1H-13C HSQC spectra and three-dimensional HNCACB, CBCA(CO)NH, HNCACB, HNCO, HCCH-TOCSY, HBHA(CO)NH, HCC-TOCSY-NNH and CC-TOCSY-NNH spectra. Distance restraints were obtained from a suite of three-dimensional, 13C- and 15N-edited NOESY-HSQC experiments using a mixing time of 80 ms. Deuterium-exchange studies were performed by lyophilizing a NMR sample and re-dissolving in 99.8% D2O (the 1H-15N HSQC spectrum of a lyophilized sample re-dissolved into 10% D2O/90% H2O was essentially identical to the 1H-15N HSQC spectrum obtained prior to lyophilization). Two-dimensional 1H-15N HSQC spectra were recorded 0.2, 0.5 and 1.0 hour after the exchange. Steady-state {1H}-15N heteronuclear NOE values (NOE = Isat/Iunsat) were measured from the ratios of 1H-15N HSQC cross peak volumes in spectra recorded in the presence (Isat) and absence (Iunsat) of three seconds of proton presaturation prior to the 15N excitation pulse.22 An overall rotational correlation time (τc) for Rv2377c was rapidly estimated from backbone amide 15N T1ρ/T1 ratios measured using a modified 1H-15N HSQC experiment to record 15N-edited one-dimensional spectra.23 All pulse programs were from the Varian BioPack suite.
2.4 Structure calculations
Structure calculations were performed iteratively using CYANA (v 2.1)24 and the 1H, 13C, and 15N chemical shift assignments and peak-picked NOESY data as experimental inputs. A total of 66 dihedral angle restraints for Phi (Φ) and Psi (Ψ) were introduced on the basis of the elements of secondary structure identified in the early structural ensembles and TALOS calculations.25 Twenty-six hydrogen bond restraints (1.8 – 2.0 Å and 2.7 – 3.0 Å for the NH–O and N-O distances, respectively) were introduced into the structure calculations on the basis of proximity in early structure calculations and, for residues in β-sheet regions, the observation of slowly exchanging amides in the deuterium exchange experiment. Alpha-helical hydrogen bond networks generally exchange before hydrogens in β-strand hydrogen bond networks26 and, for the small protein Rv2377c, had all exchanged before the first 1H-15N HSQC spectrum could be acquired (< 12 minutes).
The final ensemble of 20 CYANA derived structures were then refined with explicit water27 using force constants of 500 and 700 kcal for the NOE and dihedral restraints, respectively. The upper boundary of the CYANA distance restraints was increased by 10% and the lower bound was set to the vdw limit for the water refinement calculations. This final ensemble was then used to calculate a mean structure and average RMSD values to the mean structure using the structured regions of the protein (F13 - N55). Structural quality was assessed using the Protein Structure Validation Suite (PSVS, v1.3).28 The structural statistics are summarized in Table 1.
Table 1. Summary of the structural statistics for Rv2377ca.
Restraints for Structure Calculations | |
---|---|
Total NOEs | 602 |
Intraresidue NOEs | 142 |
Sequential (i, i + 1) NOEs | 196 |
Medium-range (i, i + j; 1 < j ≤ 4) NOEs | 77 |
Long-range (i, i + j; j > 4) NOEs | 187 |
Phi (Φ) angle restraints | 33 |
Psi (Ψ) angle restraints | 33 |
Hydrogen bond restraints | 26 |
Structure Calculations | |
Number of structures calculated | 100 |
Number of structures used in ensemble | 20 |
Structures with Restraint Violations | |
Distance Restraint Violations > 0.05Å | 0 |
Dihedral Restraint Violation > 2° | 1 |
Dihedral Restraint Violation > 3° | 0 |
RMSD to Mean (Å) Ordered Residues: 13-55 | |
Backbone N-Cα-C=O Atoms | 0.62±0.15 |
Heavy Atoms | 1.10±0.20 |
All Atoms | 1.25±0.19 |
Ramachandran Plots Ordered Residues | |
Most favored regions | 87.3% |
Additionally allowed regions | 12.4% |
Generously favored regions | 0.1% |
Disallowed | 0.1% |
Global Quality Scores - Ordered Residuesb | Z-score (Raw) |
Procheck (all) | -3.02 (-0.51) |
Procheck (Φ, Ψ) | -1.53 (-0.47) |
MolProbity clash score | -1.26 (16.22) |
All statistics are for the 20-structure ensemble deposited in the Protein Data Bank (2KHR) using the residues of the structured central core (13-55).
Calculated for the ordered residue, 13-55, using the PSVS program.28
2.5 Protein structure accession numbers
The atomic coordinates for the ensemble of 20 lowest energy structures for M. tuberculosis Rv2377c have been deposited in the RCSB under PDB code 2KHR. The chemical shifts assignments have been deposited with the BMRB under accession number 16253. The non-native three residues at the N-terminus, GSH-, are numbered sequentially starting with G1 in the RSCB and BMRB depositions. However, here the three non-native residues are numbered sequentially with an asterisk (G1*-H3*) and the first native residue, M4 in the RSCB and BMRB depositions, is labeled as M1.
3. Results and Discussion
3.1 Solution structure for Rv2377c
The elution time of Rv2377c on a size exclusion column was consistent with a monomeric 8,383 Da protein (data not shown). The experimentally estimated rotational correlation time of 6.7 ± 0.2 ns (20°C) was also more consistent with a monomeric instead of a dimeric protein.29 The line widths and chemical shift dispersion of the 1H-15N HSQC spectrum for Rv2377c, shown in Figure 1, was also characteristic of a folded, monomeric protein of molecular weight in the 8.4 kDa range. Forty-nine amide resonances were observed in the 1H-15N HSQC spectrum and 48 of these were unambiguously assigned. On the basis of these amide assignments and extensive assignment of the 13Cα and side chain proton and carbon chemical shifts (BMRB ID 16253), an ensemble of structures were calculated (Figure 2A) that satisfied all the available experimental NMR data (NOEs, chemical shifts, deuterium exchange experiments, and TALOS calculations).
As summarized in Table 1, a total of 602 interproton distance restraints, 26 hydrogen bond restraints, and 66 dihedral angle restraints were used in the final structure calculations. Each member of the final ensemble of 20 calculated structures agreed well with the experimental data with no upper limit violation greater than 0.05 Å and no torsion angle violation greater than three degrees. The quality of the structure ensemble was also shown to be good using the PSVS validation software package.28 The Ramachandran statistics for all the residues in the ensemble were overwhelmingly in acceptable space (87% of the (φ,ψ) pairs for Rv2377c were found in the most favored regions and 12% within additionally allowed regions) and all the structure quality Z-scores were acceptable (greater than minus five).
The final set of 20 calculated structures in the ensemble converge well, as shown mathematically by the statistics in Table 1 and visually by the superposition in Figure 2A. The RMSD of the structured core region (F13 - N55) in the ensemble to the mean structure is 0.62 Å for the backbone atoms (N-Cα-C=O) and 1.10 Å for all heavy atoms. Both the N- and C-terminal regions, G1*- A12 and W56 - D71, respectively, are disordered, and therefore, most of the residues at the termini are not shown in the ensemble in Figure 2A. Note that there is evidence for intermediate motion (ms to μs) at the interface between β1 and β2 (Section 3.3), and consequently, due to dynamic averaging of NOEs that bias shorter distances, the ensemble of calculated structures may also be slightly biased in this region. A cartoon representation of the secondary structure of Rv2377c is shown in Figure 2B. The central core of the protein contains a three-strand, anti-parallel β-sheet composed of residues F13-N18 (β1), S23-P26 (β2), and W35-H39 (β3). The third β-strand contains a one residue β-bulge (V38) and overall the β-sheet contains a conspicuous β-sheet twist30 as illustrated in the ensemble and the single structure closest to the average in Figure 2A and 2C, respectively. Completing the structure is a single α-helix (S44 - N55) nestled on one side of the β-sheet that is held in place by an hydrophobic core of side chains: V15 (β1), L25 (β2), V39 (β3), Y51 (α1) and V52 (α1).
3.2 Optical spectroscopy
Circular dichroism spectroscopy was used to characterize the secondary structure of Rv2377c over a range of temperatures.31 Figure 3A shows the CD spectra for Rv2377c at two temperatures. The solid line is the CD spectrum of a fresh, ∼ 0.06 mM sample collected at 25°C in the same buffer used to collect NMR data for the structure calculations. The double minimum at ∼225 and ∼207 nm and projected maximum at a wavelength < 200 nm is characteristic of a structured protein with a mixture of β-sheet, α-helical, and random coil content.31,32 Such a mixture of secondary structure is corroborated by the deconvolution of the CD data and the calculated NMR-based structure, as shown in Table 2. The red dotted line in Figure 3A is the CD spectrum of the same sample at 80°C. Relative to the spectrum collected at 25°C, the minimum at ∼225 nm has disappeared and the minimum originally at ∼207 nm has increased and shifted ∼ 2 nm to shorter wavelength. These observations at 80°C indicate that Rv2377c is more unstructured at elevated temperatures. However, the absence of an extrapolated negative minimum at ∼198 nm and a positive maximum at ∼218 nm indicates that Rv2377c is not entirely random coil at 80°C and still possesses spectral properties consistent with primarily β-sheet structure (single minimum). When the sample is cooled back to 25°C, the CD spectrum, indicated by the dashed blue line in Figure 3A, is very similar to the original CD spectrum collected prior to heating (solid black line). This indicates that the temperature-induced effects to the structure of Rv2377c are largely reversible.
To assay the thermal stability of Rv2377c, the ellipticity at 220 nm was measured as a function of temperature between 5 and 80°C. Typically, a phase transition can be detected when a structured protein becomes denatured by monitoring the increase in the ellipticity at 220 nm with increasing temperature.33,34 As shown in Figure 3B, a gradual increase in ellipticity at 220 nm is observed beginning at ∼20°C with a tailing-off starting at ∼70°C. There isn't a well-defined inflection point, but, the midpoint of the plot is around 55°C. Because the CD spectra in Figure 3A suggest that at 80°C the protein is not entirely unstructured and will refold upon cooling back to 25°C, the end point of the temperature study in Figure 3B likely does not represent a fully unstructured protein. Because β-strands are typically more robust than α-helices26 the structure remaining at high temperature may be primarily β-strands as suggested by the CD spectrum at 80°C in Figure 3A.
3.3 Dynamics
Protein dynamics often plays a role in the binding and catalysis properties of proteins at, and around, active sites.35 Information regarding the dynamics along a protein's backbone can be extracted from the properties of the amide resonances. For example, in the absence of intermolecular associations, weak or absent amide cross peaks in the 1H-15N HSQC spectrum often identify regions that are not rigidly structured in solution and qualitatively implies that these residues are undergoing conformational exchange on an intermediate timescale (millisecond to microsecond) that broadens their resonances beyond detection.35-37 The plot in Figure 4A indicate the residues with missing (solid purple column) or weak (purple asterisk) amide cross peaks in the 1H-15N HSQC spectrum of Rv2377c in Figure 1. Aside from K62, amide cross peaks are absent from W56 to D71 suggesting that the C-terminal region is unstructured in solution. Indeed, the adjacent α-helix is also somewhat dynamic (breathes) as the amide resonances in α1 all exchanged with D2O 12 minutes into the deuterium exchange experiment. The other region with a significant clustering of weak or missing amide resonances is β2 (S23 - P26) where the amide resonances were absent. While none of the β2 amide resonances were visible, most of the side chain carbon and proton resonances for β2 were assigned. The 13Cα and 13Cβ chemical shifts in β2 were characteristic of a β-strand and 1H-1H NOEs were observed between side chains of β1 and β2. The resonances of the amides in β1 facing β2, F14, L16, and N18, were also weak. Collectively, this data indicates that the S23 - P26 sequence does form a β-strand and interacts with β1, however, there is motion on the intermediate time scale (ms to μs) between the two strands.
Backbone motion on the fast time scale (picosecond) may be identified by regions with small, or negative, heteronuclear steady-state {1H}-15N NOE values.38 Figure 4B is a plot of the backbone {1H}-15N heteronuclear NOE values measured for Rv2377c. Due to spectral overlap, and weak or missing amide resonances, the only region with continuous data is between D31 - W56. The heteronuclear steady-state {1H}-15N NOE values in this region are all 0.7 or greater indicating an overall structure that is rigid and an absence of residues undergoing motion on a picosecond timescale.
3.4 An intrinsically disordered region containing a highly conserved sequence
The MbtH-like family of proteins contains over 150 members and they all share highly conserved regions as illustrated for the two MbtH-like proteins with solved structures in Figure 5.19 Universally conserved are three tryptophan residues, W25, W35, and W56. The relative orientation of these side chain are illustrated for Rv2377c in Figure 2B. The side chain indole rings of W25 and W35 sit parallel to each other at a distance of ∼9 Å, but, are not immediately over top each other. This is in slight contrast to the corresponding indole rings in both the crystal and NMR structure of PA2412 from P. aeruginosa that sit more directly over top each other at a closer distance of ∼7 and ∼8 Å, respectively. One possible explanation for the difference between the crystal structure of PA2412 and solution structure of Rv2377c is that Fo - Fc differential electron density was observed in the tryptophan pocket suggesting a small molecule of unknown identity was bound to the protein in the crystal structure.19 The third tryptophan, W56, is the first residue in the C-terminal highly conserved sequence WXDXR that is in a disordered region of the protein. Another highly conserved region, SXWP, is part of β2, a structured region with motion in the intermediate time scale. The two other highly conserved regions, (V/L)XN and PXGW, form β1 and the loop plus first residue of β3, respectively. Hence, of the four highly conserved regions of Rv2377c, two are associated with mobile elements and two are more rigid.
The last highly conserved region in MbtH-like proteins, WXDXR, is in a disordered region of the protein. Intrinsically disordered proteins represent a unique functional and structural category of proteins39, 40 implicated in several vital biological functions.41 As the name suggests, these regions lack a rigid, well-ordered structure and exist as a highly dynamic ensemble in solution. Intrinsically disordered proteins or regions of proteins are often involved in binding interactions with other proteins, nucleic acids, or small molecules, undergoing a disorder to order transition upon ligand binding.42 Relationships between amino acid sequence and intrinsic disorder have been identified, and consequently, it is possible to predict the tendency of a polypeptide to be disordered (and ordered) from the primary amino acid sequence using programs such as PONDR (www.pondr.com).43, 44 The top of Figure 4 is a graphical output of a PONDR prediction for Rv2377c plotted over the experimentally determined secondary structure. The PONDR score for residues A12 - D50 are all below 0.2, values highly predictive of an ordered structure. These residues embrace all the ordered regions of the protein determined from the NMR-based structure, including β1 and β2 residues with absent or weak amide resonances in the 1H-15N HSQC spectrum. Residues at both the N- and C-termini have PONDR scores above 0.5, values predictive of disordered structure. These termini are disordered in the ensemble of calculated NMR-based structures for Rv2377c. While it is not unusual to observed disordered regions at the termini of proteins, the presence of a highly conserved region near the C-terminal of Rv2377c suggests this may be an intrinsically disordered region of the protein still in search of its binding partner.
Further evidence that the highly conserved WXDXR sequence is intrinsically disordered is from the solution structure determined for PA2412. Figure 6 compares the XRD- and NMR-determined structures for PA2412 with the NMR-determined structure for Rv2377c. The core of each structure is similar, a three-strand anti-parallel β-sheet with a C-terminal α-helix. However, in the crystal structure of PA2412, a short, well-ordered second α-helix was also observed at the extreme end of the C-terminal. While a subset of the NMR-determined structures for PA2412 also contain a second α-helix, Figure 6 clearly indicates that this region exists as a highly dynamic ensemble in solution, as observed for Rv2377c. The dynamic C-terminal region of PA2412 also contains the highly conserved WXDXR sequence. This means that each of these two independently determined solution structures of proteins in the MbtH-like family show the highly conserved WXDXR is disordered in solution. The second ordered helix observed in the PA2412 crystal structure may be a state stabilized by crystal packing interactions, or indeed, be due to the binding of an unknown small ligand suggested by the presence of unidentifiable electron density in the crystal structure.19
3.5 Insights into biological function
To identify a possible biochemical function for Rv2377c based on its structure, the Protein Data Bank was searched for structures with similarities to Rv2377c using the DALI search engine.45 Only two proteins with DALI Z-scores greater than 3.0 were identified and these were the crystal (4.6) and NMR (3.9) structures determined for the P. aeruginosa protein PA2412. The confinement of the protein fold to the MbtH-like family of proteins may indicate that these proteins have a unique biological function.
While the exact biological function for MbtH-like family of proteins is unknown, there is substantial evidence that this protein plays a role in helping M. tuberculosis survive low-iron conditions. DNA microarray studies of M. tuberculosis response to low-iron and high-iron conditions show elevated levels of mRNA encoding Rv2377c under low-iron conditions.46 Under conditions more relevant to biological infection, inside macrophage, elevated levels of mRNA for MbtH and other genes in the nonribosomal protein synthetase clusters responsible for siderophore and antibiotic peptide synthesis were found to be intraphagosomally induced using microarray experiments.47 Some bacteria contain more than one non-ribosomal protein synthetase cluster each with their own or multiples copies of mbtH-like genes. It has been shown that the mbtH-like genes in Streptomyces coelicolor are able to cross-talk between biosynthetic pathways and can functionally replace each other.48,49 On the other hand, the entire genome of P. aeruginosa contains only one MbtH-like gene, PA2412. Studies with a deletion mutant of PA2412 demonstrated that the MbtH-like protein was necessary for the normal production or secretion of pyoveridine, a siderophore found in P. aeruginosa.19 Because the addition of pyoveridine to the PA2412 mutant cell line restored normal growth it was concluded that the MbtH-like protein was likely involved in the maturation, stabilization, or export of the siderophore. The function of PA2412 likely does not involve direct interaction with pyoveridine because MbtH-like proteins are found in gene clusters of various species that generate diverse types of siderophores. Hence, Drake et al.19 concluded that the conserved regions of the MbtH-like proteins may interact with the conserved regions of the other proteins in their gene clusters.
4. Conclusions
Rv2377c, the founding member of the MbtH-like family of proteins, is a small, 71-residue polypeptide that folds into a three-strand anti-parallel β-sheet with a C-terminal α-helix nestled onto one side. The structure is robust as CD spectroscopy shows it will refold after heating to 80°C. This core structure is similar to that observed in the XRD- and NMR-determined structure for the MbtH-like protein from P. aeruginosa, PA2412. A DALI search indicates that this fold is unique to the MbtH-like family of proteins, suggesting these proteins may also have a unique function. Further characterization of the dynamics of Rv2377c indicated that the interface between β1 and β2 displays features characteristic of motion on the ms to μs time scale and the C-terminal is highly disordered. Because these regions also contain residues highly conserved in all proteins in the MbtH-like family, the dynamics of these regions may be necessary for the hypothesized interactions with other proteins in their gene cluster. Indeed, intrinsically disordered regions are associated with binding to multiple partners50 or functional diversity,51 and hence, perhaps it is even possible that Rv2377c binds to more than one specific substrate and has more than one biological function. The observation that mtbH-like genes are able to cross-talk between biosynthetic pathways and functionally replace each other supports multiple binding partners and functional diversity.48,49 Experimental evidence suggest the MbtH-like proteins play a biochemical role in virulence as various microarray studies of the M. tuberculosis response to iron deprivation show that Rv2377c levels are upregulated. Hence, the MbtH-like family of proteins may become a target for a new generation of anti-TB agents. Further studies are necessary to uncover the biochemical function of Rv2377c with an emphasis directed at determining if it interacts with any of the other proteins within their gene cluster responsible for siderophore and antibiotic peptide synthesis. When a function for Rv2377c is found, the structure presented here will assist the molecular understanding of its function and potentially speed up the conception and development of new therapies to treat and control the spread of tuberculosis around the world.
Acknowledgments
The structure of Rv2377c was a community request made to the Seattle Structural Genomics Center for Infectious Disease (SSGCID). The research was funded by NIAID under Federal Contract No. HHSN272200700057C and performed primarily at the W.R. Wiley Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by U.S. Department of Energy's Office of Biological and Environmental Research program located at Pacific Northwest National Laboratory (PNNL). PNNL is operated for the U.S. Department of Energy by Battelle.
Footnotes
Funding: Please see Acknowledgments.
Competing interests: None declared.
Ethical approval: Not required.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Contributor Information
Garry W. Buchko, Email: garry.buchko@pnl.gov.
Chang-Yub Kim, Email: cykim@lanl.gov.
Thomas C. Terwilliger, Email: terwilliger@lanl.gov.
Peter J. Myler, Email: peter.myler@sbri.org.
References
- 1.Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization; 2007. [Google Scholar]
- 2.Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Micro Rev. 2006;19:658–85. doi: 10.1128/CMR.00061-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Mitchison DA. Drug resistance in tuberculosis. Eur Res J. 2005;25:376–9. doi: 10.1183/09031936.05.00075704. [DOI] [PubMed] [Google Scholar]
- 4.Basu S, Friedland GH, Medlock J, Andrews JR, Shah NS, Gandhi NR, Moll A, Moodley P, Sturm AW, Galvani AP. Averting epidemics of extremely drug-resistant tuberculosis. Proc Natl Acad Sci USA. 2009;106:7672–7. doi: 10.1073/pnas.0812472106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kamholz SL. Drug resistant tuberculosis. J Assoc Acad Minor Phys. 2002;13:53–6. [PubMed] [Google Scholar]
- 6.Jindani A, Nunn AJ, Enarson DA. Two 8-month regimens of chemotheraphy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet. 2004;364:1244–51. doi: 10.1016/S0140-6736(04)17141-9. [DOI] [PubMed] [Google Scholar]
- 7.Zignol M, Hosseini MS, A W, Weezenbeek CL, Nunn P, Watt CJ, Williams BG, Dye C. Global incidence of multi-drug resistant tuberculosis. J Infect Dis. 2006;194:479–85. doi: 10.1086/505877. [DOI] [PubMed] [Google Scholar]
- 8.Somu RV, Boshoff H, Qiao C, Bennett EM, Barry CE, III, Aldrich CC. Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacteria tuberculosis. J Med Chem. 2006;49:31–4. doi: 10.1021/jm051060o. [DOI] [PubMed] [Google Scholar]
- 9.Miethke M, Bissseret P, Beckering CL, Vignard D, Eustache J, Marahiel MA. Inhibition of acyl acid adenylation domains involved in bacterial siderophore synthesis. FEBS J. 2006;273:409–19. doi: 10.1111/j.1742-4658.2005.05077.x. [DOI] [PubMed] [Google Scholar]
- 10.Ratledge C. Iron, mycobacteria and tuberculosis. Tuberculosis. 2004;84:110–30. doi: 10.1016/j.tube.2003.08.012. [DOI] [PubMed] [Google Scholar]
- 11.Kostoghiorghes GJ, Weinberg ED. Iron: Mammalian defense systems, mechanisms of diseases, and chelation therapy approaches. Blood Rev. 1995;9:33–45. doi: 10.1016/0268-960x(95)90038-1. [DOI] [PubMed] [Google Scholar]
- 12.Ratledge C, Dover LG. Iron metabolism in pathogenic bacteria. Annu Rev Microbiol. 2000;54:881–941. doi: 10.1146/annurev.micro.54.1.881. [DOI] [PubMed] [Google Scholar]
- 13.Faraldo-Gómez JD, Sansom MSP. Acquisition of siderophres in Gram-negative bacteria. Nat Rev Mole Cell Biol. 2003;4:105–16. doi: 10.1038/nrm1015. [DOI] [PubMed] [Google Scholar]
- 14.Snow GA. Mycobactins: iron-chelating growth factors from mycobacteria. Bacteriol Rev. 1970;34:99–125. doi: 10.1128/br.34.2.99-125.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.De Voss JJ, Rutter K, Schroeder BG, Barry CE., III Iron acquisition and metabolism by Mycobacteria. J Bact. 1999;181:4443–51. doi: 10.1128/jb.181.15.4443-4451.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.De Voss JJ, Rutter K, Schroeder BG, Su H, Zhu Y, Barry CE., III The silicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophage. Proc Natl Acad Sci USA. 2000;97:1252–7. doi: 10.1073/pnas.97.3.1252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, III, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barell BG. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537–44. doi: 10.1038/31159. [DOI] [PubMed] [Google Scholar]
- 18.Quadri LEN, Sello J, Keating TA, Weinreb PH, Walsh CT. Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin. Chem Biol. 1998;5:631–45. doi: 10.1016/s1074-5521(98)90291-5. [DOI] [PubMed] [Google Scholar]
- 19.Drake EJ, Cao J, Qu J, Shah MB, Straubinger RM, Gulick AM. The 1.8 Å crystal structure of PA2412, an MbtH-like protein from the pyoverdine cluster of Pseudomonas aeruginosa. J Biol Chem. 2007;282:20425–34. doi: 10.1074/jbc.M611833200. [DOI] [PubMed] [Google Scholar]
- 20.Buchko GW, Kim CY, Terwilliger TC, Kennedy MA. Solution structure of the conserved hypothetical protein Rv2302 from Mycobacterium tuberculosis. J Bact. 2006;188:5993–6001. doi: 10.1128/JB.00460-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, Markley JL, Sykes BD. 1H, 13C and 15N Chemical shift referencing in biomolecular NMR. J Biomol NMR. 1995;6:135–40. doi: 10.1007/BF00211777. [DOI] [PubMed] [Google Scholar]
- 22.Farrow NA, Muhandiram DR, Singer AU, Pascal SM, Kay LE, Gish G, Shoelson SE, Pawson T, Forman-Kay JD. Backbone dynamics of a free and a phosphopeptide-complexed Src homlogy 2 domain studied by 15N NMR relaxation. Biochemistry. 1994;33:5984–6003. doi: 10.1021/bi00185a040. [DOI] [PubMed] [Google Scholar]
- 23.Szyperski T, Yeh D, Sukumaran D, Moseley H, Montelione G. Reduced-dimensionality NMR spectroscopy for high-throughput protein resonance assignment. Proc Natl Acad Sci USA. 2002;99:8009–14. doi: 10.1073/pnas.122224599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Guntert P. Automated NMR structure calculation with CYANA. Meth Mol Biol. 2004;278:353–78. doi: 10.1385/1-59259-809-9:353. [DOI] [PubMed] [Google Scholar]
- 25.Cornilescu G, Delagio F, Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR. 1999;13:289–301. doi: 10.1023/a:1008392405740. [DOI] [PubMed] [Google Scholar]
- 26.Creighton TE. Proteins: structure and molecular properties. New York: H.W. Freeman & Company; 1993. [Google Scholar]
- 27.Linge JP, Nilges M. Influence of non-bonded parameters on the quality of NMR structures: A new force field for NMR structure calculation. J Biomol NMR. 1999;13:51–9. doi: 10.1023/a:1008365802830. [DOI] [PubMed] [Google Scholar]
- 28.Bhattacharya A, Tejero R, Montelione G. Evaluating protein structures determined by structural genomics consortia. Proteins. 2007;66:778–95. doi: 10.1002/prot.21165. [DOI] [PubMed] [Google Scholar]
- 29.Palczewska M, Groves P, Ambrus A, Kaeta A, Kover K, Batta G, Kuznicki J. Structural and biochemical characterization of neuronal calretinin domain I-II (residues 1-100) Eur J Biochem. 2001;268:6229–37. doi: 10.1046/j.0014-2956.2001.02575.x. [DOI] [PubMed] [Google Scholar]
- 30.Chothia C. Conformation of twisted β-pleated sheets in proteins. J Mol Biol. 1973;75:295–302. doi: 10.1016/0022-2836(73)90022-3. [DOI] [PubMed] [Google Scholar]
- 31.Woody RW. Studies of theoretical circular dichroism of polypeptides: Contributions of β-turns. New York: John Wiley & Sons; 1974. [Google Scholar]
- 32.Holzwarth GM, Doty P. The ultraviolet circular dichroism of polypeptides. J Amer Chem Soc. 1965;87:218–28. doi: 10.1021/ja01080a015. [DOI] [PubMed] [Google Scholar]
- 33.Buchko GW, Hess NJ, Bandaru V, Wallace SS, Kennedy MA. Spectroscopic studies of zinc(II)- and colbalt(II)-associated Escherichia coli formamidopyrimidine-DNA glycosylase (Fpg): extended X-ray absorption fine structure evidence for a metal-binding domain. Biochemistry. 2000;40:12441–9. doi: 10.1021/bi001377k. [DOI] [PubMed] [Google Scholar]
- 34.Karantzeni I, Ruiz C, Liu CC, LiCata VJ. Comparative thermal denaturation of Thermus aquaticus and Escherichia coli type 1 DNA polymerases. Biochem J. 2003;374:785–92. doi: 10.1042/BJ20030323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Ishima R, Torchia DA. Protein dynamics from NMR. Nat Struct Biol. 2000;7:740–3. doi: 10.1038/78963. [DOI] [PubMed] [Google Scholar]
- 36.Millet O, Loria JP, Kroenke CD, Pons M, Palmer AG., III The static magnetic field dependence of chemical shift exchange linebroadening defines the NMR chemical shift time scale. J Amer Chem Soc. 2000;122:2867–77. [Google Scholar]
- 37.Buchko GW, McAteer K, Wallace SS, Kennedy MA. Solution-state NMR investigation of DNA binding interactions in Escherichia coli formamidopyrimidine-DNA glycosylase (Fpg): a dynamic description of the DNA/protein interface. DNA Repair. 2005;4:327–39. doi: 10.1016/j.dnarep.2004.09.012. [DOI] [PubMed] [Google Scholar]
- 38.Mandel AM, Akke M, Palmer AG., III Backbone dynamics of Escherichia coli ribonuclease H1 correlations with structure and function in an active enzyme. J Mol Biol. 1995;246:144–63. doi: 10.1006/jmbi.1994.0073. [DOI] [PubMed] [Google Scholar]
- 39.Tompa P. Instrinsically unstructured proteins. Trends Biochem Sci. 2002;27:527–33. doi: 10.1016/s0968-0004(02)02169-2. [DOI] [PubMed] [Google Scholar]
- 40.Fink AL. Natively unfolded proteins. Curr Opin Struct Biol. 2005;15:35–41. doi: 10.1016/j.sbi.2005.01.002. [DOI] [PubMed] [Google Scholar]
- 41.Dunker AK, Brown CJ, Lawsor JD, Iahoucheva LM, Obradovic Z. Intrinsic disorder and protein function. Biochemistry. 2002;41:6573–82. doi: 10.1021/bi012159+. [DOI] [PubMed] [Google Scholar]
- 42.Uversky VN. Intrinsically disordered proteins and their environement: Effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding. Protein J. 2009;28:305–25. doi: 10.1007/s10930-009-9201-4. [DOI] [PubMed] [Google Scholar]
- 43.Li X, Romero P, Rani M, Dunker AK, Obradovic Z. Predicting protein disorder for N-, C- and internal regions. Genome Info. 1999;10:30–40. [PubMed] [Google Scholar]
- 44.Romero P, Obradovic Z, Li X, Garner EC, Brown CJ, Dunker AK. Sequence complexity of disordered protein. Proteins. 2001;42:38–48. doi: 10.1002/1097-0134(20010101)42:1<38::aid-prot50>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- 45.Holm L, Sander C. Touring protein fold space with Dali/FSSP. Nucleic Acids Res. 1998;26:316–9. doi: 10.1093/nar/26.1.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Rodriguez GM, Voskuil MI, Gold B, Schoolnik GK, Smith I. IdeR, an esential gene in Mycobacterium tuberculosis: Role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response. Infect Immun. 2002;70:3371–81. doi: 10.1128/IAI.70.7.3371-3381.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C, Schoolnik GK. Transcriptional adaption of Mycobacterium tuberculosis within macrophages: Insights into the phagosomal environment. J Exp Med. 2003;198:693–704. doi: 10.1084/jem.20030846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Wolpert M, Gust B, Kammerer B, Heide L. Effects of deletions of mbtH-like genes on clorobiocin biosynthesis in Streptomyces coelicolor. Microbiology. 2007;153:1413–23. doi: 10.1099/mic.0.2006/002998-0. [DOI] [PubMed] [Google Scholar]
- 49.Lautru S, Oves-Costales D, Pernodet JL, Challis GL. MbtH-like protein-mediated cross-talk between non-ribosomal peptide antibiotic and siderophore biosynthetic pathways in Streptomyces coelicolor M145. Microbiology. 2007;153:1405–12. doi: 10.1099/mic.0.2006/003145-0. [DOI] [PubMed] [Google Scholar]
- 50.Haynes C, Oldfield E, Ji F, Klitgord N, Cusick ME, Radivojac P, Uversky VN, Vidal M, Iahoucheva LM. Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput Biol. 2006;2:e100. doi: 10.1371/journal.pcbi.0020100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Xie H, Vucetic S, Iahoucheva LM, Oldfield E, Dunker AK, Uversky VN, Obradovic Z. Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions. J Proteome Res. 2007;6:188–1898. doi: 10.1021/pr060392u. [DOI] [PMC free article] [PubMed] [Google Scholar]